Tenecteplase offers “incredible opportunity” to optimise thrombolytic stroke treatments
Earlier this year, results from the Canadian AcT (Alteplase compared to tenecteplase) randomised controlled trial (RCT) were delivered for the first time at the...
NeuroNews’ top 10 most popular stories of September 2022
The latest and greatest in neurointerventional clinical research buzzed our readers in September, with new studies on dual antiplatelet therapy (DAPT) duration, radial versus...
How AI, automation, robotics and other innovations in ultrasound are improving stroke care
Robert Hamilton (Los Angeles, USA) outlines several key milestones in the history of stroke care, and discusses how recent technological advances in this space...
NeuroNews’ top 10 most popular stories of August 2022
In August, NeuroNews’ most read stories included new clinical data on a number of neurovascular technologies, physician viewpoints on a “historic” neurointerventional procedure in...
